Our global partner, High Grade Pharmaceutical Co., Ltd., has applied for a patent "Drug having Steroids and Fatty Compound" in Taiwan, China und USA at the beginning of the year 2017. The first product of the patent, based on DMS® technology and Fluticasone Propionate (INN), a pharmaceutical drug similar to hydrocortisone, was developed with KOKO and launched in Taiwan recently. Among others it is recommended for acute, inflamed cases of neurodermatitis. Advantage: After fast remission of the skin reactions the treatment can be continued subsequently by cosmetic prevention, e.g. with DMS® base cream High Classic Plus. For the first time pharmaceutical treatment is combined with sustained corneotherapy by means of lamellar creams.
Lamellar Fluticasone cream